New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 2, 2014
07:33 EDTMNKDMannKind shares may 'overshoot to the upside,' says JPMorgan
JPMorgan believes shares of MannKind may "overshoot to the upside" following the positive FDA panel vote given the significant short interest in the name as well as the company’s "passionate" retail following. JPMorgan remains concerned about the commercial potential of Afrezza and keeps a Neutral rating on MannKind.
News For MNKD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 29, 2014
19:32 EDTMNKDMannKind confirms receipt of $150M licensing upfront payment
Subscribe for More Information
September 24, 2014
17:01 EDTMNKDMannKind announces closing of global licensing agreement with Sanofi
Subscribe for More Information
September 17, 2014
05:51 EDTMNKDStocks with implied volatility movement; OREX MNKD
Stocks with implied volatility movement; Orexigen (OREX) 91, MannKind (MNKD) 60 according to iVolatility.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use